President BidenJoe Biden’s administrationBiden is still seizing land near the border, despite plans to halt the construction of the wall: report on the Olympics, climate on the agenda of Biden’s meeting with Japanese Prime Minister Boner for Afghanistan: “It’s time to withdraw troops” MORE faces a series of new obstacles to controlling the coronavirus pandemic in the United States.
Several states have seen a rise in cases, with millions of Americans being vaccinated every day, in part due to the lifting of restrictions on masks and business and general pandemic fatigue more than a year after the virus began to spread widely. More contagious variants are spreading across the country, and experts warn that new variants may emerge until the country reaches a higher level of immunity.
This week, the Food and Drug Administration (FDA) recommended a break in the use of the Johnson & Johnson vaccine. While many health experts have hailed it as the right move, a long pause could cause vaccine hesitation, another challenge for Biden.
The CDC panel on Wednesday did not specify when or whether to issue new recommendations for the use of the shot, meaning the break could last several weeks.
The president has won high praise for his pandemic response so far from both health experts and the public. A poll in Monmouth this week found that 62 percent of adults say Biden did a good job with the coronavirus pandemic, a figure higher than the 54 percent who approve of Biden̵
But current failures may pose some challenges to these figures.
“I don’t think this reflects specifically on Biden, but it could slow down overall efforts to restore the country and add fuel to the skepticism that many Americans still have about the vaccine,” said Johnson, a Democratic vaccine development strategist. Johnson.
Although the delay in Johnson & Johnson will not disrupt the delivery of vaccine doses in the country, it denies the nation the only approved shot that can be delivered in a single dose and a vaccine that is easier to store than the Pfizer and Moderna vaccines.
This may make it difficult to obtain vaccines for more vulnerable groups and have left some public health officials to criticize the decision, arguing that it will lead to greater vaccine volatility and slow recovery.
“[The panel’s] the decision to wait would be good if there was no pandemic, “wrote Ashish Ja, dean of the Brown School of Public Health, in a tweet. “But they are. And waiting 7-10 days won’t do much. I’m not sure what data they’ll get at that time. But we’re going to do real damage to a great vaccine, especially suitable for vulnerable populations.”
The White House insists its plan to have enough doses of vaccines for all American adults by the end of May will not be disrupted by the break.
White House spokesman Jen PsakiJen PsakiDefending at Night: Administration Says Russia Has Low to Moderate Confidence Behind Afghanistan Awards | “Low to medium risk” of Russia’s invasion of Ukraine over the next few weeks Intelligence leaders face sharp questions during House’s global threats. Healthcare at night: Johnson & Johnson’s delay draws criticism of CDC panel | Pfizer CEO says third dose of COVID-19 vaccine “likely” needed within a year | CDC finds that less than 1% of fully vaccinated people have received COVID-19 Hillicon Valley: Biden administration sanctions Russia for hacking SolarWinds, interfering in MORE described the FDA process as the “gold standard” during a briefing on Thursday, and said the administration would let the process play out, while remaining focused on vaccinating every adult American.
“We remain confident that we have the supplies needed to meet demand,” she said. “Because we are too prepared and too delivered, we remain confident in that.”
The rate of daily vaccinations has been steadily increasing over the past few weeks, with officials announcing this week that the United States currently has an average of 3 million coronavirus vaccines each day, with 3.5 million doses administered on Wednesday. To date, nearly 200 million Americans have received at least one dose of the vaccine.
Still, vaccine hesitation was a problem even before the news. Monmouth found that 21 percent of adults in the United States say they are unlikely to receive the vaccine – up from 24 percent in March, but they are still high.
Michael Osterholm, an epidemiologist who served on Biden’s CIVID-19 advisory board during the transition, acknowledged that the decision to pause the vaccine could create more hesitation about the Johnson & Johnson vaccine in particular, but identified it as a necessary step. to demonstrate transparency around the vaccination process to the public.
“If there is any sense that something is hiding, I think it will create irreparable damage in terms of the credibility of our ability to continue to follow these vaccination programs,” Osterholm said.
Michigan is among the states where there is a sharp increase in new cases and this has led to some friction between the governor and the White House.
Manager Gretchen WhitmerGretchen Whitmer Watch Live: Whitmer Provides COVID-19 Update in Michigan Numerous GOP Michiganders Positive for COVID-19 Following White House District Meeting on Whitmer’s Pandemic Work: “Serious” Sand Shown MORE (D), who was considered a vice president, asked the administration to increase vaccine doses to the state to prevent an increase in cases, but the administration said it would not do so. The head of the CDC claims that the most effective way to slow the spread would be to restore some restrictions, something Whitmer does not want to do, given the fatigue of the restrictions in her condition. Whiter faces re-election next year.
Biden called on governors to restore mandates in countries where they have been removed and to reconsider easing some restrictions, warning that too many Americans believe the pandemic fight is over.
Health experts have expressed confidence that by the summer, through a combination of warmer weather and a more widely vaccinated public, the country is likely to pass the current jump in cases. Still, Osterholm said the battle was not over.
“I think what’s happening in Minnesota, Michigan and starting to happen in other states is a warning that we’re not done yet,” he said.
Officials have tried to respond to fluctuations among racial and ethnic minority groups, as well as Republican voters, which polls suggest are much more likely than Democrats to oppose vaccines.
The Biden administration is investing resources to convince hesitant populations that the vaccine is safe and effective and reaches underserved communities, including deploying a network of 275 organizations, including sports leagues, business and religious groups, and other community organizations, to coordinate efforts. to inspire public confidence in the vaccine.
The Biden administration has also invested $ 3 billion in the president’s $ 1.9 trillion bailout package to support state and local efforts to increase vaccine use in minorities and rural communities.
But health experts describe the problem of hesitation as a complex challenge that requires officials to understand the rationale for any group that has expressed reluctance and to deal with the problems independently.
“When you start looking at all the different countries that may not want to be vaccinated, there is no real answer. “Part of the challenge is that you can’t just put up a billboard that says you’re getting vaccinated,” Osterholm said.